Updated hourlyHourly refreshMon, Sep 21, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · SaaS
(PR-inside.com) Three-year enterprise agreement with a total three year contract value of approximately US$78,000 (approximately EUR 67,000) in total, covering an enterprise-wide deployment and full Epic and MyChart integration. LONDON, GB / ACCESS Newswire / September 14, 2026 / Physitrack PLC (STO:PTRK), a global provider of digital health and wellbeing technology, today announces that it has been selected as the digital rehabilitation platform for a US metropolitan safety net healthcare system, following a competitive selection process. The agreement covers a three-year relationship with a break option after the second year. It represents annual recurring revenue of approximately US$26,500 (approximately EUR 22,800) in the ..
Sep 14 · 06:00·PR-Inside
Healthcare
- Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - TOKYO and GSTAAD, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Abe Yoando Pharma Co., Ltd., a nearly 300-year-old...
Sep 14 · 06:00·PR Newswire
Healthcare
Elder Care has released a mobile application that allows family caregivers to photograph and store medical documents from doctors and hospitals, providing centralized access for authorized family members.
Sep 14 · 05:40·PressReleaseNews
Healthcare
Allschwil, Switzerland, September 14, 2026
Sep 14 · 05:15·GlobeNewswire
Healthcare
SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for...
Sep 14 · 04:26·PR Newswire
Healthcare
RYBREVANT plus chemotherapy demonstrates durable benefit with a differentiated approach that dual-targets EGFR and MET Results mark significant progress for a patient population with poor outcomes and a historical five-year survival rate of just 8% SEOUL, South Korea, Sept. 13, 2026...
Sep 14 · 01:45·PR Newswire
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 13, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Sep 13 · 22:02·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 13, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Sep 13 · 15:01·PR-Inside
Healthcare · Education
Ribbon-cutting held on World Suicide Prevention Day RED BANK, N.J., Sept. 12, 2026 /PRNewswire/ -- Red Bank Catholic High School officially opened a new Wellness Room on its Broad Street campus today, with a ribbon-cutting and blessing ceremony marking the next chapter of the school's...
Sep 13 · 00:01·PR Newswire
Healthcare
Basel, 13 September 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) today announced that its collaborator MediLink released interim results from the randomised phase III TAISHAN-302 trial evaluating Tam-Peli (tambotatug pelitecan, YL201) versus topotecan in Chinese patients with relapsed small-cell lung cancer (SCLC) who progressed after prior platinum-based chemotherapy with or without a PD-L1 inhibitor. 1 The trial met its primary endpoint of overall survival (OS) with Tam-Peli demonstrating a statistically significant and clinically meaningful OS benefit, reducing the risk of death by 54% (median OS 13.3 vs. 9.4 months; stratified HR=0.46; p<0.0001). Tam-Peli also showed robust efficacy across secondary endpoints, significantly extending progression-free survival (PFS) (median PFS 7.4 vs.
Sep 13 · 00:00·GlobeNewswire
Finance · Healthcare
NEW YORK, Sept. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hims & Hers Health, Inc. (NYSE: HIMS) between August 4, 2025 and July 29, 2026, both dates inclusive (the "Class Period"), of the important November 2, 2026...
Sep 12 · 16:25·PR Newswire
Healthcare
(PR-inside.com) In a recent interview Vantage Hemp's Chief Medical Officer says healthcare needs standardized, reproducible products and controlled clinical trials - as CMS carries its cannabinoid initiative into the 10-year LEAD Medicare model WASHINGTON, D.C. / ACCESS Newswire / September 12, 2026 / MMJ International Holdings, Inc., together with MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively, "MMJ"), says the federal government's cannabinoid experiment on seniors is confronting a basic problem that policy cannot solve: Physicians still have to decide what they are willing to give their patients. The Centers for Medicare & Medicaid Services created the Substance Access Beneficiary Engagement Incentive, ..
Sep 12 · 15:45·PR-Inside